List of top 200 securities held by Viking Global Opportunities Parent GP LLC:
- Institutional investors with $100 million or more in holdings are required to report their portfolio holdings on a quarterly basis within 45 days of the end of a calendar quarter.
- The table below lists top 200 holdings for the reported quarter.
- Portfolio values with missing quarterly reports are assigned zero.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| 1 | API GROUP CORP COM APG | 2024-06-18 | 27,032,516 | $973.441M ($36.01) | 37.86% |  | | Form4 |
| 2 | BRIDGEBIO PHARMA INC BBIO | 2025-01-31 | 22,055,375 | $777.011M ($35.23) | 30.22% | | | Form4 |
| 3 | ACUREN CORP COM TIC | 2025-02-14 | 34,360,000 | $337.415M ($9.82) | 13.12% | | | Form4 |
| 4 | ROIVANT SCIENCES LTD SHS ROIV | 2023-06-26 | 12,884,307 | $138.377M ($10.74) | 5.38% | | | Form4 |
| 5 | GINKGO BIOWORKS HLDGS INC DNA | 2022-03-04 | 15,676,379 | $119.14M ($7.60) | 4.63% | | | Form4 |
| 6 | INHIBRX BIOSCIENCES INC INBX | 2024-06-03 | 7,150,826 | $86.954M ($12.16) | 3.38% | | | Form4 |
| 7 | STANDARD BIOTOOLS INC. LAB | 2024-03-20 | 58,651,170 | $72.727M ($1.24) | 2.83% | | | Form4 |
| 8 | Inhibrx Biosciences Inc. INBX | 2024-06-07 | 2,047,397 | $24.896M ($12.16) | 0.9682% | | | Form4 |
| 9 | PROCEPT BIOROBOTICS CORP COM PRCT | 2022-03-22 | 298,205 | $16.61M ($55.70) | 0.6459% | | | Form4 |
| 10 | 4D MOLECULAR THERAPEUTICS INC. FDMT | 2024-01-05 | 4,247,914 | $14.528M ($3.42) | 0.5650% | | | Form4 |
Showing 1 to 10 of 12 entries
×